Published

Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver Disease

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Digestive and Liver Disease
Date: 2025-02-01
Source: OpenAlex
DOI: 10.1016/j.dld.2025.01.135
PubMed: Unavailable

Authors

Martina Colognesi Daniela Gabbia A. Signor Stefano Comai Andrea Mattarei Gianfranco Pasut Franco Folli Lucia Centofanti S. La Rosa G Finzi M. Pappagallo Paolo Manfredi Sara De Martin

Watch author

Derived topics and classifications

psilocybin Pharmacology Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver Disease2025-02-01

Related papers

‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injuryInternal Medicine Journal · 2026-01-01 Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto RatsPsychedelic Medicine · 2025-12-16 The Rise of Psilocybin Use in the United States: A Multisource Observational Study.Annals of internal medicine · 2025-07-01 Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-10-01 Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06 “To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-25 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trialCommunications Medicine · 2026-07-30